Hoyoung Huh
CIK 1401267 · Chairman, Scientific Adv. Bd. · last filed 2025-12-18
Hoyoung Huh is a Chairman, Scientific Adv. Bd. who has filed 54 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for AKTX, was dated Dec 18, 2025. Current disclosed insider exposure totals $64.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$64.93M
7
54
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKTX | Director | 4,805,311 | $13.40 | $64.39M | $0 | 3 | 2025-12-18 |
| PLRX | Director | 239,619 | $1.13 | $270.8K | $0 | 6 | 2025-06-09 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Director | — | — | — | $0 | 1 | 2018-06-22 |
| CTMX | Director | — | $3.01 | — | $0 | 3 | 2018-06-15 |
| GERN | Director | 154,301 | $1.15 | $177.4K | $0 | 19 | 2018-05-17 |
| FACT | Director | 8,333 | $10.65 | $88.7K | $0 | 1 | 2009-09-09 |
| NKTR | Chief Operating Officer | — | $59.38 | — | $0 | 6 | 2008-12-04 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-18 | AKTX | Buy (P) | — | $0 | EDGAR |
| 2025-06-09 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2025-03-24 | AKTX | Grant (A) | — | $0 | EDGAR |
| 2025-03-10 | AKTX | Grant (A) | +892,857 | $1000.0K | EDGAR |
| 2024-11-18 | — | Mixed | −8,755,682 | $0 | |
| 2024-06-17 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2023-09-25 | — | Buy (P) | +45,000 | $0 | |
| 2023-09-21 | — | Buy (P) | +80,000 | $0 | |
| 2023-09-19 | — | Buy (P) | +25,000 | $0 | |
| 2023-09-15 | — | Buy (P) | +50,000 | $0 |